News – Page 862 – Endpoints News

Another antibiotic maker bites the dust, as Tetraphase is swallowed for cheap

6 years ago

Biogen staffer fled to China in search of emergency Covid-19 testing, care — and now faces criminal charges

6 years ago

EMA offers free scientific advice for Covid-19 developers

6 years ago

Unum gets a reprieve from the FDA — partial hold lifted after 9 days

6 years ago

'We're led by the science': UK's plan to delay coronavirus peak and pursue herd immunity triggers uproar

6 years ago

BioNTech teams up with Fosun Pharma to test Covid-19 mRNA vaccine in China — and scores $50M investment

6 years ago

Covid-19 roundup: Regeneron, Sanofi launch coronavirus program; NIH staffer tests positive for coronavirus, Moderna ...

6 years ago

Trump administration tries to lure German coronavirus vaccine maker to US — reports

6 years ago

Biogen’s Covid-19 tally breaks past the 100 mark, feeding the state total as the contagion wreaks havoc

6 years ago

Biotech entrepreneurs Arie Belldegrun and Cedric Francois test positive for Covid-19 — and here's why they want you ...

6 years ago

CureVac’s Ingmar Hoerr tells us why he returned to take on a pandemic; NGM loses a president

6 years ago

Bavencio from Merck KGaA, Pfizer encounters yet another trial setback

6 years ago

The E100 biotech survey: Execs are hunkering down for the pandemic, worried about longterm fallout — but eager to ...

6 years ago

Eli Lilly teams with antibody upstart AbCellera in coronavirus hunt

6 years ago

FDA offers Roche an emergency OK for coronavirus testing tech — easing a critical logjam

6 years ago

Tainted donations from stool bank reignite safety concerns about poop transplants

6 years ago

Partnered with Gilead and Sanofi, protein degradation specialist Nurix bags $120M to chart its own clinical path

6 years ago

Biogen outbreak continues to spur new coronavirus cases in Massachusetts as health officials struggle to keep up with ...

6 years ago

A one-time biotech unicorn gets slaughtered as lead program is scrapped, highlighting lingering trouble

6 years ago

CureVac founder back at the helm; Merck extends immunomodulatory drug discovery program with Sutro

6 years ago

Coronavirus: WHO declares pandemic, EMA meetings go virtual

6 years ago

Atlas-backed Kymera grabs $102M as its protein degradation technology heads into clinic

6 years ago

Vir’s George Scangos teams up with his former colleagues at Biogen to press fast-forward on antibody programs for ...

6 years ago

Flagship merges two startups to build a $220M Repertoire of T cell tech, therapies

6 years ago

First page Previous page 859 860 861862863 864 865 Next page Last page